TVARDI THERAPEUTICS, INC. Accounts Receivable, Related Parties, Current
TVARDI THERAPEUTICS, INC. (TVRD) had Accounts Receivable, Related Parties, Current of $10.12 million as of 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Notes › Receivables
us-gaap:AccountsReceivableRelatedPartiesCurrent · last filed 2023-08-07
- 2023-06-30: Accounts Receivable, Related Parties, Current $10.12M.
- 2023-03-31: Accounts Receivable, Related Parties, Current $6.07M.
- 2022-12-31: Accounts Receivable, Related Parties, Current $3.26M.
- 2022-09-30: Accounts Receivable, Related Parties, Current $9.62M.
| Period end | Accounts Receivable, Related Parties, Current |
|---|---|
| 2023-06-30 | $10.12M 10-Q · filed 2023-08-07 |
| 2023-03-31 | $6.07M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $3.26M 10-Q · filed 2023-08-07 |
| 2022-09-30 | $9.62M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $8.00M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $2.50M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $0.00 10-Q · filed 2022-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |